The predictive value of C-reactive protein to albümin ratio for ascending aort progression in patients with ascending aortic diameter of 40-50 mm

J Cardiothorac Surg. 2022 Oct 4;17(1):254. doi: 10.1186/s13019-022-02003-5.

Abstract

We aimed to investigate the ability of the C-reactive protein-to-albumin ratio (CAR) to predict ascending aorta progression in patients with 40-50 mm diameter of ascending aortic dilatation. A total of 182 diagnosed patients with ascending aortic diameters of 40-50 mm were enrolled in this study. The study population was divided into tertiles based on yearly ascending aortic growth rate values. Group I (n = 137) was defined as a value in the lower 2 tertiles (ascending aorta growth ≤ 1.00 mm/year), and group II (n = 45) was defined as a value in the third tertile (ascending aorta growth > 1.00 mm/year). Hypertension, chronic obstructive pulmonary disease, positive family history, and CAR were found to be independent risk factors for ascending aorta growth > 1.00 mm/year. The area under the ROC curve (AUC) of CAR was 0.771(95% CI 0.689-0.854) for predicting ascending aorta growth > 1.00 mm/year. In patients with 40-50 mm ascending aneurysms, CAR may be useful to predict ascending aorta progression.

Keywords: Aneurysm; Ascending aorta; C-reactive protein-to-albumin ratio; Computed tomography; Inflammation.

MeSH terms

  • Albumins
  • Aorta
  • Aortic Diseases* / etiology
  • C-Reactive Protein
  • Dilatation, Pathologic / complications
  • Humans
  • Hypertension* / complications
  • Receptors, Immunologic
  • Risk Factors

Substances

  • Albumins
  • CRP protein, human
  • Receptors, Immunologic
  • C-Reactive Protein